Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancers
US11208484B2 · kind B2 · utility
2Cited by
0References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 9, 2017 |
| Grant date | Dec 28, 2021 |
| Priority date | — |
| Expiry date | Mar 25, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is the use of a combination of an anti-PD-1 antibody and a VEGFR inhibitor in the preparation of a drug for treating cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.